CHR. HANSEN A/S: Financial statements 2025
CVR: 12516479
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
CHR. HANSEN A/S (CVR 12516479) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 6,820,616,000 and a net result of DKK 2,105,477,000 compared with DKK 1,891,419,000 the year before. That is an increase of 1.5% compared with the year before. The profit margin was 30.9%. Equity in the 2025 report amounted to DKK 11,263,718,000. The solvency ratio was 66.9%. The company had 1,629 employees in the financial year.
- Revenue
- DKK 6,820,616,000
- Gross Profit
- DKK 4,436,065,000
- Profit/Loss
- DKK 2,105,477,000
- Equity
- DKK 11,263,718,000
- Total Assets
- DKK 16,845,685,000
- Employees
- 1,629
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 6.8B | 4.4B | 2.1B | 11.3B | 1629 |
| 2024 | 6.7B | 3.8B | 1.9B | 10.1B | 1614 |
| 2022 | 5.9B | 3.6B | 1.2B | 7.4B | 1567 |
| 2021 | 5.4B | 3.3B | 812.7M | 7.1B | 1528 |
| 2020 | 5.4B | 3.3B | 1.2B | 6.6B | - |
Official annual report
How creditworthy is CHR. HANSEN A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
CHR. HANSEN A/S has published its annual report for 2024. Revenue came to DKK 6,716,636,000, and the net result was DKK 1,891,419,000.
About CHR. HANSEN A/S
CHR. HANSEN A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 1988. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named CHR. HANSEN'S LABORATORIUM DANMARK A/S and A/S PSE NR. 2770. The management consists of Morten Enggaard Rasmussen. The board consists of Rainer Chapour Lehmann (chair), Anders Lund, Helle Rexen and Lisbet Kragelund. The company is owned by NOVOZYMES A/S. The company has 1,747 employees (2026). In 2025, the company reported revenue of DKK 6,820,616,000 and a net result of DKK 2,105,477,000 compared with DKK 1,891,419,000 the year before. Equity in the 2025 report amounted to DKK 11,263,718,000.